Lantern Pharma Inc’s filing revealed that its 10% Owner Fletcher Aaron G.L. unloaded Company’s shares for reported $0.12 million on Jun 13 ’25. In the deal valued at $3.09 per share,40,000 shares were sold. As a result of this transaction, Fletcher Aaron G.L. now holds 49,957 shares worth roughly $0.18 million.
Then, Kreis Leslie W. sold 40,000 shares, generating $123,600 in total proceeds. Upon selling the shares at $3.09, the 10% Owner now owns 49,957 shares.
Before that, Fletcher Aaron G.L. sold 60,647 shares. Lantern Pharma Inc shares valued at $204,987 were divested by the 10% Owner at a price of $3.38 per share. As a result of the transaction, Fletcher Aaron G.L. now holds 51,860 shares, worth roughly $0.18 million.
H.C. Wainwright initiated its Lantern Pharma Inc [LTRN] rating to a Buy in a research note published on October 07, 2021; the price target was $32.
Price Performance Review of LTRN
On Tuesday, Lantern Pharma Inc [NASDAQ:LTRN] saw its stock jump 12.38% to $3.54. Over the last five days, the stock has gained 12.03%. Lantern Pharma Inc shares have fallen nearly -17.48% since the year began. Nevertheless, the stocks have risen 10.97% over the past one year. While a 52-week high of $6.12 was reached on 01/24/25, a 52-week low of $2.55 was recorded on 04/08/25.
Levels Of Support And Resistance For LTRN Stock
The 24-hour chart illustrates a support level at 3.36, which if violated will result in even more drops to 3.17. On the upside, there is a resistance level at 3.73. A further resistance level may holdings at 3.91.
How much short interest is there in Lantern Pharma Inc?
A steep rise in short interest was recorded in Lantern Pharma Inc stocks on 2025-06-13, growing by 21313.0 shares to a total of 0.28 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.25 million shares. There was a rise of 7.72%, which implies that there is a positive sentiment for the stock.
